Long-Lasting Protection Offered by COVID-19 Vaccines: Study Analysis
Analysis of vaccine efficacy data demonstrates long-lasting protection provided by Pfizer, Moderna, and Johnson & Johnson COVID-19 vaccines, supporting the ongoing vaccination efforts and public health strategies to control the spread of SARS-CoV-2.
August 2022
Diagnostic Methods for COVID-19: Review of Main Approaches and Challenges
Accurate diagnosis of COVID-19 is crucial for pandemic control, with a review published in The Lancet evaluating the main diagnostic methods, challenges, and implications for effective disease management and surveillance.
August 2022
Long COVID Less Likely in Fully Vaccinated Individuals: Comparative Analysis
Vaccination with at least two doses substantially decreases the reporting of long COVID symptoms, underscoring the protective effect of vaccination against persistent symptoms following SARS-CoV-2 infection and supporting vaccination efforts to mitigate the long-term consequences of COVID-19.
August 2022
Global Dementia Cases to Triple by 2050: Study Identifies Risk Factors
A study analyzing risk factors for dementia predicts a tripling of global dementia cases by 2050, emphasizing the need for preventive strategies targeting modifiable risk factors such as smoking, obesity, diabetes, and low educational attainment.
August 2022
WHO Recommends Two Treatments for COVID-19: Baricitinib and Sotrovimab
The WHO recommends two new treatments, baricitinib and a monoclonal antibody drug sotrovimab, for the treatment of COVID-19, based on emerging evidence of their efficacy and safety in reducing disease severity and mortality.
August 2022
COVID-19 Vaccine Booster Effective Against Omicron Variant: Clinical Confirmation
A study confirms that three doses of the COVID-19 vaccine, including a booster dose, provide effective protection against the Omicron variant, supporting the implementation of booster vaccination strategies to enhance immunity and control the spread of SARS-CoV-2 variants.
August 2022
COVID-19 Pandemic Continues with Omicron Variant: Epidemiological Projections
Despite the emergence of the Omicron variant, the COVID-19 pandemic is expected to continue, with a large proportion of the world population projected to be infected by March 2022, underscoring the need for ongoing surveillance and control measures to manage the pandemic.
August 2022
Syndemic Theory and Acute Illness: Implications for Public Health Interventions
The syndemic theory, which describes the clustering of epidemics arising from harmful social conditions, provides insights into the complex interplay between social determinants, health disparities, and disease outcomes, informing holistic approaches to public health interventions.
August 2022
Global Impact of Antibiotic Resistance: Public Health Warning
Antibiotic resistance poses a significant global health threat, with an estimated 1.2 million deaths projected by 2029, underscoring the urgent need for coordinated action to combat antimicrobial resistance and preserve the effectiveness of existing antibiotics.
August 2022
Subjective Knee Inflammation in Knee Osteoarthritis: Clinical Observations
The frequency and clinical characteristics of people with knee osteoarthritis reporting subjective knee inflammation in the absence of objective inflammation provide insights into the subjective experience of knee symptoms and underscore the importance of patient-reported outcomes in assessing disease severity and treatment response.
August 2022
